NTRA Natera, Inc.

289.92USD+0.15%Mkt Cap: 42.04B USDP/E: —

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence mon…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap42.04B USD
Enterprise Value41.12B USD
Revenue (TTM)2.91B USD
Gross Profit1.49B USD
Net Income (TTM)-208.16M USD
Revenue/Share20.51 USD
Last Price289.92 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees6.1K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-836.32
PEG—
EV/EBITDA-233.88
EV/Revenue14.14
P/S14.45
P/B22.38
EPS (TTM)-1.01 USD
EPS (Forward)-0.35 USD
52W Range
181.0042% of range437.41
52W High437.41 USD
52W Low181.00 USD
Profitability
Gross Margin64.75%
Oper. Margin-8.54%
EBITDA Margin-6.04%
Profit Margin-9.03%
ROE-12.16%
ROA-8.68%
ROIC-28.29%
ROCE-15.84%
Growth
Revenue Growth34.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF215.30M USD
CapEx (TTM)139.19M USD
FCF Margin2.91%
FCF Yield0.20%
Net Debt-858.35M USD
Net Debt/EBITDA4.88
Net Debt/FCF-10.15
Balance Sheet
Debt/Equity0.13
Current Ratio2.81
Quick Ratio2.56
Book Value/Sh12.95 USD
Cash/Share7.57 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)412.36 USD
Upside (mean)+42.2%
Target Range280.00 USD – 500.00 USD
280.00+42.2% to mean500.00
# Analysts21
Ownership
Shares Out.145.00M
Float141.00M
Insiders2.71%
Institutions96.30%
Short Interest
Short Ratio3.7d
Short % Float4.33%
Short % Out.4.21%
Shares Short6.07M
Short (prev mo.)6.36M
Technical
SMA 50378.90 (-23.5%)
SMA 200271.65 (+6.7%)
Beta1.51
S&P 52W Chg12.08%
Avg Vol (30d)1.95M
Avg Vol (10d)2.75M
Technical Indicators
RSI (14)29.5
MACD-27.0206
MACD Signal-18.9256
MACD Hist.-8.0950
BB Upper458.51 USD
BB Middle353.85 USD
BB Lower249.19 USD
BB Width59.15%
ATR (14)21.06 USD
Vol Ratio (20d)1.21x

About Natera (NASDAQ: NTRA)

›

Natera (NASDAQ: NTRA) is listed on Nasdaq, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 6,135 employees.

The shares were at 289.92 USD on 19 November 2026, up 46.1% over 52 weeks. Its 52-week range is 181.00 USD to 437.41 USD: the price is 33.7% below the high and 60.2% above the low.

Its market capitalisation is 42.04B USD.

Natera reports return on equity of -12.2%, an operating margin of -8.5% and revenue up 34.1% year over year.

It holds more cash than debt, a net cash position of 858.35M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 21 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 412.36 USD is 42.2% above the current price. The next earnings report is expected on 25 February 2027.